Published in Medical Devices and Surgical Technology Week, January 14th, 2007
The investors include Crescent International Ltd. and Leviticus Partners LP and funds managed by Corsair Capital Management and Lewis Asset Management.
Trimedyne recently received U.S. Food and Drug Administration (FDA) clearance to market a new, side firing laser fiber for use with Holmium lasers for their FDA cleared indications, including the treatment of benign...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week